Consistent with these findings, prehabilitation was associated with a reduction in 7-day morbidity among patients with myosteatosis, compared with ERAS alone ( p = 0.045), whereas the corresponding difference at 30 days did not reach statistical significance ( p = 0.151).
← all excerpts
Identifying Patients with Colorectal Cancer Likely to Benefit from a Trimodal Prehabilitation Prior to Surgery.
1
0.1510
0.1510